Biotech News

BD to Present at Wells Fargo 21st Annual Healthcare Conference

Becton Dickinson (BDX)Becton DickinsonConference / presentation

, /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 21 st Annual Healthcare Conference on Wednesday, September 9, 2026, at 9:30 a.m. Eastern Time.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.

About BD BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X @BDandCo or Instagram @becton_dickinson .

View original content: https://www.prnewswire.com/news-releases/bd-to-present-at-wells-fargo-21st-annual-healthcare-conference-302860873.html

SOURCE BD (Becton, Dickinson and Company)

Released August 26, 2026

Related news

Becton Dickinson

Global Medical Technology BD is a large medical-technology company supplying products used across medication delivery, connected care, biopharmaceutical manufacturing and interventional procedures. Medical Essentials The company manufactures needles, syringes, catheters, vascular-access products and other high-volume devices used...

Recent company news

Stock data

Close
181.38 USD
Market cap
39.8B USD
Exchange
NYSE
Sector
Biopharma
Location
United States